The Global Swine Mycoplasma Pneumonia Live Vaccine Market Size was estimated at USD 235.46 million in 2023 and is projected to reach USD 337.81 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.
Report Overview:
Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
This report provides a deep insight into the global Swine Mycoplasma Pneumonia Live Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Swine Mycoplasma Pneumonia Live Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Swine Mycoplasma Pneumonia Live Vaccine market in any manner.
Global Swine Mycoplasma Pneumonia Live Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Zoetis
- Boehringer Ingelheim
- Merck
- HIPRA
- Ceva Sant Animale
- Harbin Pharmaceutical Group
- Qilu Animal Health Products
- Guangdong Winsun Bio-Pharmaceutical
- Jilin HeYuan Bioengineering
- Jofunhwa Biotechnology
Market Segmentation (by Type)
- 168 Strains
- RM48 Strains
- Other
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Swine Mycoplasma Pneumonia Live Vaccine Market
- Overview of the regional outlook of the Swine Mycoplasma Pneumonia Live Vaccine Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Swine Mycoplasma Pneumonia Live Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Swine Mycoplasma Pneumonia Live Vaccine
1.2 Key Market Segments
1.2.1 Swine Mycoplasma Pneumonia Live Vaccine Segment by Type
1.2.2 Swine Mycoplasma Pneumonia Live Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Swine Mycoplasma Pneumonia Live Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Swine Mycoplasma Pneumonia Live Vaccine Market Competitive Landscape
3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Swine Mycoplasma Pneumonia Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Sales Sites, Area Served, Product Type
3.6 Swine Mycoplasma Pneumonia Live Vaccine Market Competitive Situation and Trends
3.6.1 Swine Mycoplasma Pneumonia Live Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Swine Mycoplasma Pneumonia Live Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Swine Mycoplasma Pneumonia Live Vaccine Industry Chain Analysis
4.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Swine Mycoplasma Pneumonia Live Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Swine Mycoplasma Pneumonia Live Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2019-2024)
7 Swine Mycoplasma Pneumonia Live Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Sales by Application (2019-2024)
7.3 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Growth Rate by Application (2019-2024)
8 Swine Mycoplasma Pneumonia Live Vaccine Market Segmentation by Region
8.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Region
8.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Region
8.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Swine Mycoplasma Pneumonia Live Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Swine Mycoplasma Pneumonia Live Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Zoetis
9.1.1 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.1.2 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.1.4 Zoetis Business Overview
9.1.5 Zoetis Swine Mycoplasma Pneumonia Live Vaccine SWOT Analysis
9.1.6 Zoetis Recent Developments
9.2 Boehringer Ingelheim
9.2.1 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.2.2 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.2.4 Boehringer Ingelheim Business Overview
9.2.5 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine SWOT Analysis
9.2.6 Boehringer Ingelheim Recent Developments
9.3 Merck
9.3.1 Merck Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.3.2 Merck Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.3.4 Merck Swine Mycoplasma Pneumonia Live Vaccine SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 HIPRA
9.4.1 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.4.2 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.4.4 HIPRA Business Overview
9.4.5 HIPRA Recent Developments
9.5 Ceva Sant? Animale
9.5.1 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.5.2 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.5.3 Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.5.4 Ceva Sant? Animale Business Overview
9.5.5 Ceva Sant? Animale Recent Developments
9.6 Harbin Pharmaceutical Group
9.6.1 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.6.2 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.6.4 Harbin Pharmaceutical Group Business Overview
9.6.5 Harbin Pharmaceutical Group Recent Developments
9.7 Qilu Animal Health Products
9.7.1 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.7.2 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.7.4 Qilu Animal Health Products Business Overview
9.7.5 Qilu Animal Health Products Recent Developments
9.8 Guangdong Winsun Bio-Pharmaceutical
9.8.1 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.8.2 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.8.4 Guangdong Winsun Bio-Pharmaceutical Business Overview
9.8.5 Guangdong Winsun Bio-Pharmaceutical Recent Developments
9.9 Jilin HeYuan Bioengineering
9.9.1 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.9.2 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.9.4 Jilin HeYuan Bioengineering Business Overview
9.9.5 Jilin HeYuan Bioengineering Recent Developments
9.10 Jofunhwa Biotechnology
9.10.1 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Basic Information
9.10.2 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Overview
9.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Market Performance
9.10.4 Jofunhwa Biotechnology Business Overview
9.10.5 Jofunhwa Biotechnology Recent Developments
10 Swine Mycoplasma Pneumonia Live Vaccine Market Forecast by Region
10.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast
10.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Region
10.2.4 South America Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Swine Mycoplasma Pneumonia Live Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Swine Mycoplasma Pneumonia Live Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Swine Mycoplasma Pneumonia Live Vaccine by Type (2025-2030)
11.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Swine Mycoplasma Pneumonia Live Vaccine by Type (2025-2030)
11.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Swine Mycoplasma Pneumonia Live Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Mycoplasma Pneumonia Live Vaccine as of 2022)
Table 10. Global Market Swine Mycoplasma Pneumonia Live Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Sales Sites and Area Served
Table 12. Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Product Type
Table 13. Global Swine Mycoplasma Pneumonia Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Swine Mycoplasma Pneumonia Live Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Swine Mycoplasma Pneumonia Live Vaccine Market Challenges
Table 22. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Type (Kilotons)
Table 23. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size by Type (M USD)
Table 24. Global Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Swine Mycoplasma Pneumonia Live Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons) by Application
Table 30. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size by Application
Table 31. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Application (2019-2024)
Table 35. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Swine Mycoplasma Pneumonia Live Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Swine Mycoplasma Pneumonia Live Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Swine Mycoplasma Pneumonia Live Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 44. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 45. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Zoetis Business Overview
Table 47. Zoetis Swine Mycoplasma Pneumonia Live Vaccine SWOT Analysis
Table 48. Zoetis Recent Developments
Table 49. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 50. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 51. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Boehringer Ingelheim Business Overview
Table 53. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine SWOT Analysis
Table 54. Boehringer Ingelheim Recent Developments
Table 55. Merck Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 56. Merck Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 57. Merck Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Swine Mycoplasma Pneumonia Live Vaccine SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 62. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 63. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. HIPRA Business Overview
Table 65. HIPRA Recent Developments
Table 66. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 67. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 68. Ceva Sant? Animale Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Ceva Sant? Animale Business Overview
Table 70. Ceva Sant? Animale Recent Developments
Table 71. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 72. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 73. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Harbin Pharmaceutical Group Business Overview
Table 75. Harbin Pharmaceutical Group Recent Developments
Table 76. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 77. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 78. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Qilu Animal Health Products Business Overview
Table 80. Qilu Animal Health Products Recent Developments
Table 81. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 82. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 83. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Guangdong Winsun Bio-Pharmaceutical Business Overview
Table 85. Guangdong Winsun Bio-Pharmaceutical Recent Developments
Table 86. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 87. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 88. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Jilin HeYuan Bioengineering Business Overview
Table 90. Jilin HeYuan Bioengineering Recent Developments
Table 91. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Basic Information
Table 92. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Overview
Table 93. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jofunhwa Biotechnology Business Overview
Table 95. Jofunhwa Biotechnology Recent Developments
Table 96. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Swine Mycoplasma Pneumonia Live Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Swine Mycoplasma Pneumonia Live Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Swine Mycoplasma Pneumonia Live Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Swine Mycoplasma Pneumonia Live Vaccine Market Size by Country (M USD)
Figure 11. Swine Mycoplasma Pneumonia Live Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Swine Mycoplasma Pneumonia Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Swine Mycoplasma Pneumonia Live Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Swine Mycoplasma Pneumonia Live Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Type
Figure 18. Sales Market Share of Swine Mycoplasma Pneumonia Live Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Swine Mycoplasma Pneumonia Live Vaccine by Type in 2023
Figure 20. Market Size Share of Swine Mycoplasma Pneumonia Live Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Swine Mycoplasma Pneumonia Live Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Application
Figure 24. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Application in 2023
Figure 26. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Application (2019-2024)
Figure 27. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share by Application in 2023
Figure 28. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Swine Mycoplasma Pneumonia Live Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Swine Mycoplasma Pneumonia Live Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Region in 2023
Figure 44. China Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Swine Mycoplasma Pneumonia Live Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Swine Mycoplasma Pneumonia Live Vaccine Market Share Forecast by Application (2025-2030)
